A startling turn of events has seen ex-President Donald Trump start to impose broad new levies on the heavy-truck and pharmaceutical industries, a move that is already shaking investor opinion and stressing equity markets. Set to go into effect on October 1, 2025, the policies define the most extensive tariff projects unveiled in recent years.
Any branded or patented pharmaceutical item brought into the U.S. would be subject to a 100% tax under the new law unless the manufacturing firm builds a domestic plant (better than Trumps’ threat to push 250% Tariffs on Drug Imports
With global and U.S. stocks mostly pulling back
Economists claim that this tariff drive arrives at a sensitive time. Still a constant menace, inflation is under tight monitoring of the underlying price pressures by the U.S. Federal Reserve
Countries selling pharmaceuticals or hefty machinery to the U.S. can file official objections at the World Trade Organization
